1228376-15-5

Basic information

• Product Name: ethyl 3-chloro-4-cyanobenzoate
• Synonyms: ethyl 3-chloro-4-cyanobenzoate
• CAS NO: 1228376-15-5
• Molecular Weight: 209.632
• Mol File: 1228376-15-5.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 345.8±27.0 °C(Predicted)
• Density: 1.28±0.1 g/cm3(Predicted)
• CAS DataBase Reference: ethyl 3-chloro-4-cyanobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3-chloro-4-cyanobenzoate(1228376-15-5)
• EPA Substance Registry System: ethyl 3-chloro-4-cyanobenzoate(1228376-15-5)

Safety Data

• Hazardous Substances Data: 1228376-15-5(Hazardous Substances Data)

Upstream product

• 25118-59-6 4-bromo-3-chlorobenzoic acid 
• 120077-67-0 4-bromo-3-chlorobenzoic acid ethyl ester 

Downstream Products

• 1228376-16-6 ethyl 3-chloro-4-(N'-hydroxycarbamimidoyl)benzoate 

Relevant articles and documents

HETEROCYCLIC COMPOUND

The problem of the present invention is to provide a compound having a superior RORγt inhibitory action, and useful as a prophylactic or therapeutic agent for psoriasis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, rheumatoid arthritis, multiple sclerosis, uveitis, asthma, ankylopoietic spondylarthritis, systemic lupus erythematosus, chronic obstructive pulmonary disease or the like. The present invention relates to a compound represented by the formula (I): [wherein each symbol is as described in the DESCRIPTION] or a salt thereof, which has an RORγt inhibitory action, and useful as a prophylactic or therapeutic agent for psoriasis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, rheumatoid arthritis, multiple sclerosis, uveitis, asthma, ankylopoietic spondylarthritis, systemic lupus erythematosus, chronic obstructive pulmonary disease or the like.